Print this page

Arthritis and autoimmune illnesses comprise some of the most important health problems today. With nearly 4 million Canadians suffering from rheumatoid arthritis, osteoarthritis, lupus, or one of the other 110 forms of arthritis, the cost to our healthcare system is staggering. And the cost in quality of life for arthritis patients - and their families - cannot be overestimated. Our researchers have determined to change this bleak picture. They have a real chance to succeed - with your help.

Canada's two most prestigious arthritis research facilities - the Arthritis Centre for Excellence at Toronto Western Hospital and The Wellesley Hospital's Arthritis & Autoimmune Research Centre - have merged to form the Wellesley Toronto Arthritis & Immune Disorder Research Centre at University Health Network. The Centre is home to over 30 principal investigators whose expertise span the spectrum - from molecular biology, to experimental therapeutics, to community-based prevention.

There is reason for optimism. Our Division of Advanced Therapeutics has introduced the first biological therapy into Canada with remarkable success. Our molecular biologists have discovered a new gene that is at the heart of inflammatory response in arthritis. Our storehouse of patient information is being mined constantly for revealing factors that can be used to improve treatment and outcomes.

Most importantly, our researchers are backed by a foundation that can make the difference: the Arthritis & Autoimmunity Research Centre Foundation. The Directors of the Foundation are dedicated to providing the fuel that runs the research engine - dollars for salaries, equipment and facilities. Upon this base of support, our researchers compete for grants and contracts, and raise an additional $3 for every $1 provided by the Foundation. That's teamwork! And that is why, with your help, our team is going to make the difference.

Dr. Christopher J. Paige
Vice President, Research
University Health Network